Form 4 Tracker
Brett R Hagen

Chief Accounting Officer · 1 filing · Latest: Mar 19, 2026

Kalaris Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
KLRS
Brett R HagenChief Accounting OfficerMar 20, 2026
Sale
$6.721,915$12.9K0
KLRS
BRETT R R HAGENMar 20, 2026
Proposed Sale
$6.721,915$12.9K
KLRS
Hagen Brett RFeb 21, 2025
Proposed Sale
$10.0796$967
KLRS
Hagen Brett RJan 23, 2025
Proposed Sale
$9.4736$341
KLRS
Hagen Brett RJan 10, 2025
Proposed Sale
$0.4398332$146
KLRS
Hagen Brett RNov 19, 2024
Proposed Sale
$0.5451554$302
KLRS
Hagen Brett RNov 5, 2024
Proposed Sale
$0.86471,655$1.4K
KLRS
Hagen Brett ROct 22, 2024
Proposed Sale
$0.7675486$373
KLRS
Hagen Brett ROct 21, 2024
Proposed Sale
$0.7787479$373
KLRS
Hagen Brett ROct 3, 2024
Proposed Sale
$0.814301$245